The proposed rule amendments are intended to update the language for definitions.

 

DEPARTMENT OF HEALTH

Board of Clinical Laboratory Personnel

RULE NO.:RULE TITLE:

64B3-5.0011Definitions

PURPOSE AND EFFECT: The proposed rule amendments are intended to update the language for definitions.

SUMMARY: To update the rule language.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 483.805, 483.823 FS.

LAW IMPLEMENTED: 483.823 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Anthony B. Spivey, Executive Director, Board of Clinical Laboratory Personnel, 4052 Bald Cypress Way, Bin # C07, Tallahassee, Florida 32399-3257.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B3-5.0011 Definitions.

(1) “AAB” means The American Association of Bioanalysts.

(2) “ABB” means The American Board of Bioanalysis.

(3) “ABCC” means American Board of Clinical Chemistry.

(4) “ABD” means American Board of Dermatology.

(5) “ABFT” means American Board of Forensic Toxicology.

(6) “ABHES” means The Accrediting Bureau of Health Education Schools.

(7) “ABHI” means The American Board of Histocompatibility and Immunogenetics.

(8) “ABIM” means American Board of Internal Medicine.

(9) “ABMG” means American Board of Medical Genetics.

(10) “ABMLI” means American Board of Medical Laboratory Immunology.

(11) “ABMM” means American Board of Medical Microbiology.

(12) “ABNM” means American Board of Nuclear Medicine.

(13) “ABOMP” means American Board of Oral & Maxillofacial Pathology.

(14) “ABP” means American Board of Pathology.

(15) “AMT” means American Medical Technologists.

(16) “AOBD” means American Osteopathic Board of Dermatology.

(17) “AOBIM” means American Osteopathic Board of Internal Medicine.

(18) “AOBNM” means American Osteopathic Board of Nuclear Medicine.

(19) “AOBP” means American Osteopathic Board of Pathology.

(20) “ASCPi” means The American Society for Clinical Pathology International Certification.

(21) “ASCP” means The American Society for Clinical Pathology.

(22) “BB” means Blood Banking.

(23) “BOC” means ASCP Board of Certification.

(24) “CAAHEP” means The Commission on Accreditation of Allied Health Education Programs.

(25) “CG” means Cytogenetics.

(26) “CHS” means Certified Histocompatibility Specialist.

(27) “CHT” means Certified Histocompatibility Technologist.

(28) “CT” means Cytotechnologist.

(29) “DLM” means Diplomat Laboratory Management.

(30) “ELD” means Embryology Laboratory Director.

(31) “GS” means General Supervisor.

(32) “HCLD” means High Complexity Laboratory Director.

(33) “HT” means Histotechnician.

(34) “HTL” means Histotechnologist.

(35) “MB” means Microbiology.

(36) “MDT” means Molecular Diagnostics Technologist.

(37) “MLT” means Medical Laboratory Technician.

(38) “MLS” means Medical Laboratory Scientist.

(39) “MP” means Molecular Pathology.

(40) “MT” means Medical Technologist.

(41) “NAACLS” means The National Accrediting Agency for Clinical Laboratory Science.

(42) “NRCC” means the National Registry of Certified Chemists.

(43) “QIHC” means Qualification in Immunohistochemistry.

(44) “SBB” means Specialist in Blood Banking.

(45) “SC” means Specialist in Chemistry.

(46) “SCT” means Specialist in Cytotechnology.

(47) “SH” means Specialist in Hematology.

(48) “SM” means Specialist in Microbiology.

(49) “SMB” means Specialist in Molecular Biology.

(50) “TS” means Technical Supervisor.

(51) “Academic Science” means college level courses in the areas of chemistry, biology, physiology, anatomy, microbiology, immunology, medical sciences, genetics, physics and molecular biology, pursuant to subsectionas defined in rule 64B3-2.003(6), F.A.C. The term does not include applied science as defined in subsection 64B3-2.003(6), F.A.C.

(52) “Bachelor’s Degree” means a four year baccalaureate degree from a regionally accredited college or university.

(53) “Bachelor’s Degree in Medical Technology” means a four year baccalaureate degree earned at an accredited program, pursuant to subsection 64B3-2.003(9), F.A.C.

(54) “Medical Technology Training Program” means an ABHES, CAAHEP, NAACLS, board approved training program for clinical/medical laboratory scientists or medical technologists, pursuant to subsections 64B3-2.003(9) and (16), F.A.C., or Department of Defense programs that are equivalent to a board approved training program.

(55) “Semester Hour” means one hour of credit in an accredited college or university, pursuant to subsection 64B3-2.003(1), F.A.C., or foreign education equated, pursuant to subsection 64B3-6.002(6), F.A.C.

Rulemaking Authority 483.805, 483.823 FS. Law Implemented 483.823 FS. History–New 6-29-06, Amended 12-16-07, 4-28-10, 1-30-12, 12-25-13, 11-25-14, 2-21-16, 4-18-18, 12-31-19,                           .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Clinical Laboratory Personnel

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Clinical Laboratory Personnel

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: November 20, 2020

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: February 5, 2021